NAT10 and adrenal cortex carcinoma: In addition, compared with low expression levels, high expression levels of NAT10 were correlated with poorer DFS in ACC, HNSC and LIHC, but not in KIRP and PCPG in GEPIA2 (Figures 3N–R).